Inner Mongolia Furui Medical Science Co., Ltd. (SHE:300049)

SHE:300049 Income Statement

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020
Operating Revenue	1,411	1,342	1,147	1,001	891.56	800.96
Other Revenue	8.5	7.49	6.9	7.37	6.93	6.57
Revenue	1,420	1,349	1,154	1,009	898.48	807.53
Revenue Growth (YoY)	11.63%	16.93%	14.37%	12.27%	11.26%	-2.91%
Cost of Revenue	374.82	350.73	291.39	267.67	239.14	226.65
Gross Profit	1,045	998.28	862.34	741.09	659.34	580.88
Selling, General & Admin	630.56	584.24	527.56	474.49	405.7	361.47
Research & Development	99.24	99.49	82.47	70.82	64.79	65.82
Other Operating Expenses	9.11	8.08	10.43	10.79	12.5	11.39
Operating Expenses	758.41	711.59	622	562.68	491.94	440.51
Operating Income	286.57	286.69	240.34	178.41	167.4	140.38
Interest Expense	-2.98	-2.77	-0.9	-1.58	-2.33	-3.21
Interest & Investment Income	18.51	16.07	12.38	9.73	10.54	3.41
Currency Exchange Gain (Loss)	-22.44	10.37	-2.31	7.93	16.48	-12.48
Other Non Operating Income (Expenses)	-1.7	-2.03	4.08	-1.28	-0.26	-0.25
EBT Excluding Unusual Items	277.95	308.34	253.59	193.21	191.83	127.84
Impairment of Goodwill	-7.7	-7.7	-	-	-	-
Gain (Loss) on Sale of Investments	-21.18	-23.11	-	-	-	-1.6
Gain (Loss) on Sale of Assets	-0.69	-0.31	-0.82	-1.86	-3.46	-6.93
Asset Writedown	0.01	-0	-4.71	-0	-	-
Other Unusual Items	-10.45	-6.66	-12.66	0.29	0.77	-5.32
Pretax Income	237.93	270.55	235.4	191.63	189.14	113.99
Income Tax Expense	75.85	74.67	58.29	46.22	41.1	23.72
Earnings From Continuing Operations	162.09	195.88	177.11	145.41	148.04	90.27
Minority Interest in Earnings	-72.23	-82.59	-75.55	-47.52	-52.57	-28.36
Net Income	89.86	113.29	101.56	97.89	95.47	61.91
Net Income to Common	89.86	113.29	101.56	97.89	95.47	61.91
Net Income Growth	-32.50%	11.54%	3.75%	2.54%	54.22%	42.69%
Shares Outstanding (Basic)	265	264	263	263	260	256
Shares Outstanding (Diluted)	265	264	263	263	260	256
Shares Change (YoY)	0.56%	0.50%	-0.01%	1.30%	1.31%	0.03%
EPS (Basic)	0.34	0.43	0.39	0.37	0.37	0.24
EPS (Diluted)	0.34	0.43	0.39	0.37	0.37	0.24
EPS Growth	-32.87%	10.98%	3.76%	1.22%	52.22%	42.65%
Free Cash Flow	9.98	2.44	115.66	98.69	142.94	90.41
Free Cash Flow Per Share	0.04	0.01	0.44	0.38	0.55	0.35
Dividend Per Share	-	-	-	0.200	-	-
Gross Margin	73.60%	74.00%	74.74%	73.47%	73.38%	71.93%
Operating Margin	20.18%	21.25%	20.83%	17.69%	18.63%	17.38%
Profit Margin	6.33%	8.40%	8.80%	9.70%	10.63%	7.67%
Free Cash Flow Margin	0.70%	0.18%	10.03%	9.78%	15.91%	11.20%
EBITDA	360.56	358.88	307.52	236.39	221.12	209.72
EBITDA Margin	25.39%	26.60%	26.65%	23.43%	24.61%	25.97%
D&A For EBITDA	73.99	72.19	67.18	57.98	53.71	69.35
EBIT	286.57	286.69	240.34	178.41	167.4	140.38
EBIT Margin	20.18%	21.25%	20.83%	17.69%	18.63%	17.38%
Effective Tax Rate	31.88%	27.60%	24.76%	24.12%	21.73%	20.81%
Revenue as Reported	1,420	1,349	1,154	1,009	898.48	807.53
Advertising Expenses	-	3.34	4.76	9.83	9.3	5.62

Source: S&P Global Market Intelligence. Standard template. Financial Sources.